Nitrofuran derivative
Treatment of Chagas' disease, sleepin sickness
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01 ANTIPROTOZOALS
P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
P01CC Nitrofuran derivatives
P01CC01 Nifurtimox
D00833 Nifurtimox (USAN/INN) <US>
USP drug classification [BR:br08302]
Antiparasitics
Antiprotozoals
Nifurtimox
D00833 Nifurtimox (USAN/INN)
Drug groups [BR:br08330]
Antiparasitic
DG01554 5-Nitrofuran antiprotozoal
D00833 Nifurtimox
Antimicrobials [BR:br08307]
Antiparasitics
Agents against Leishmaniasis and Trypanosomiasis
Nitrofuran derivatives
D00833 Nifurtimox (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00833
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00833
Other DBs
CAS:
23256-30-6
PubChem:
7847898
ChEBI:
7566
LigandBox:
D00833
NIKKAJI:
J16.764I
KCF data
ATOM 19
1 C1x C 22.2169 -9.9561
2 N1y N 22.2169 -11.3680
3 N2b N 20.9942 -12.0740
4 C2b C 19.7885 -11.3777
5 C8y C 18.5909 -12.0691
6 O2x O 17.4768 -11.2406
7 C8y C 16.3491 -12.0475
8 C8x C 16.7680 -13.3694
9 C8x C 18.1547 -13.3794
10 N2b N 15.1264 -11.3415 #+
11 O3a O 13.9035 -12.0475 #-
12 O3a O 15.1269 -9.9564
13 C1y C 23.4293 -12.0680
14 C1x C 24.6418 -11.3680
15 S2x S 24.6418 -9.9561
16 C1x C 23.4293 -9.2561
17 C1a C 23.4297 -13.4399
18 O3c O 25.8459 -10.6512
19 O3c O 25.3369 -8.7520
BOND 20
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 6 7 1
7 7 8 2
8 8 9 1
9 5 9 2
10 7 10 1
11 10 11 1
12 10 12 2
13 2 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 1 16 1
18 13 17 1
19 15 18 2
20 15 19 2